Risk Reduction: Controlled Substance Tapers in Clinical Practice

Wednesday, April 26, 2023, 12:01 AM - Sunday, April 26, 2026, 11:59 PM


AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Attendance (1.00 hours)

Safe tapering of controlled substances reduces negative impacts on the health and wellness of patients. In this module we will discuss the necessity of taper planning in clinical practice to reduce risk of negative patient outcomes.

1. Outline the factors that determine when a patient should be tapered off opioids
2. Review the increased clinical risks of multiple controlled substances co-prescribed with opioids
3. Provide guidance on pain management and opioid tapering with a patient using empathy
4. Provide a framework for a controlled substance taper plan with monitoring and follow-up

Spectrum Health Hospitals designates this Enduring Material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Accessibility Statement
 
Spectrum Health is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CE Conference Coordinator.

Spectrum Health adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

Spectrum Health adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.